Jeffrey Boone, M.D.
Founder and Director of the Boone Heart Institute
Estimated Time of Talk
45 min webcast = 0.75 credits
15 min Q&A = 0.25 credits
Total = 1.00 credits
This webinar will cover clinical implications and therapeutic approaches to patients who are poor responders to aspirin therapy.
- Learn how aspirin therapy reduces cardiovascular events.
- Review how 11-dhTXB2 levels can indicate aspirin effectiveness.
- Therapeutic considerations and additional testing for those who are poor responders to aspirin therapy.
Conflicts of Interest
Speaker- Amgen, Aralez, Cleveland HeartLab
This enduring material activity, Aspirin Effectiveness and its Influence on Cardiovascular Risk, has been reviewed and is acceptable for up to 1.00 prescribed credits by the American Academy of Family Physicians. Term of approval begins May 1, 2017. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.